Quest Diagnostics, a provider of diagnostic information services, completed the acquisition of Blueprint Genetics, a specialty genetic testing company. Financial terms were not disclosed. "The great challenge with genetic testing is generating quality, actionable and broadly accessible insights from vast quantities of sequenced genetic data. Blueprint Genetics has developed a proven model for delivering highly specialized genetic insights that we believe we can scale to serve new patient populations with unmet clinical needs. The addition of Blueprint Genetics strengthens and extends the Quest value proposition in genetics, delivering on our Accelerate growth strategy and vision of a healthier world," Steve Rusckowski, Quest Diagnostics Chairman, President and CEO.